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Cyclo-oxygenase (COX), which catalyses the conversion of arachidonic acid
to prostaglandin endoperoxide and prostanoids, is widely expressed in mam-
malian organs. The aim of the study was to evaluate the immunoexpression
of the constitutive and inducible cyclo-oxygenase isoforms (COX-1 and COX-2
respectively) in the oesophagus, stomach and the small and large bowels of
untreated rat dams and foetuses on gestational day 21. The localisation of
the COX isoforms was similar in the maternal and foetal organs, although
the intensity of the reaction for COX-2 was stronger in the foetuses. Cyto-
plasmic COX-1 immunostaining was found in myocytes of the muscularis
propria, muscularis mucosae and the blood vessels. It was also positive in
the endothelial cells, scattered stromal cells of the lamina propria and the
ganglion cells of the nerve plexus in the bowels. Apart from the keratinised
layer, a strong reaction was revealed in the stratified squamous epithelium
of the oesophagus and forestomach. Negative or weakly positive staining
was found in the mucus-secreting cells covering the surface, gastric pits
and pyloric glands, as well as in the parietal cells and the chief cells. Weakly
positive COX-1 immunostaining was observed in epithelial cells of the small
intestine crypts, but in some cases enterocytes and goblet cells covering
villi were also positive. In the colonic mucosa weak COX-1 staining was
typical of the absorptive, and goblet cells. The COX-2 immunostaining was
nuclear and/or cytoplasmic. An inconsistent positive reaction was seen in
the muscle of the muscularis mucosae, muscularis propria and the blood
vessels. Positive staining was also found in scattered stromal cells of the
lamina propria and adventitia and the ganglion cells. Weak nuclear staining
was found in the stratified squamous epithelium of the oesophagus and
forestomach. Unlike the strong foetal reactivity in the epithelial cells of the
glandular stomach, a negative or weakly positive reaction was seen in the
maternal parietal and/or mucous-secreting surface stomach cells. Some epi-
thelial cells of the crypts both in the small and large bowel were also COX-2
positive. In conclusion, constitutive and inducible COX isoforms were
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INTRODUCTION
Numerous experimental and clinical studies have
shown that cyclo-oxygenase inhibitors, also known
as non-steroidal anti-inflammatory drugs, may dam-
age the gastrointestinal mucosa. The harmful effect
is mediated by various mechanisms including topical
injury, increased expression of intercellular adhesion
molecules, thromboxane depletion, and probably the
most important, inhibition of prostaglandin synthe-
sis [12, 22]. 6-keto-prostaglandins increase epithelial
cell proliferation, stimulates mucin, bicarbonate and
phospholipid secretion, which protects the gas-
troduodenal mucosa against hydrochloric acid, pep-
sin and bile salts. Unlike that of gastroduodenal inju-
ry, the pathogenesis of oesophageal, jejunal and ileal
mucosa injury is still unclear. It is suggested that the
drugs, in spite of prostaglandin synthesis blockade,
directly uncouple oxidative metabolism in the mito-
chondria of the enterocytes. This leads to cell dam-
age and an increase in intestinal mucosal permeabil-
ity, thus permits bacteria and bile from the lumen to
penetrate the intestinal wall and to cause deep dam-
age [19, 22].
Synthesis of prostaglandins, as well as of other
prostanoids depends initially on cyclo-oxygenase
(COX) activity, also known as prostaglandin-endop-
eroxide synthase (EC 1.14.99.1). Two main isoforms
of the enzyme have been detected so far. COX-1 is
constitutively expressed in most of the tissues and
catalyses prostanoid synthesis, which is believed to
support the physiological functions of the organs.
COX-2, in contrast, is induced by various pathologi-
cal factors, including stress, proinflammatory cytok-
ines, growth factors and endotoxins [22]. However,
it has also been detected physiologically, for instance
in the brain, kidney, lung, male and female repro-
ductive organs, placenta and some foetal tissues
[4, 6, 9, 22, 24, 25]. Recently, a new isoform, COX-3,
has also been revealed in the central nervous system.
This is regarded as a post-translational modification
of COX-1 [3], but there are also data linking the iso-
form to COX-2 [28].
Although there have been a number of studies
showing COX expression in the gastric mucosa, en-
zyme localisation has not been studied extensively in
the oesophagus or the small and large intestines,
especially in foetuses. The aim of this study was to
evaluate the immunoexpression of the constitutive
(COX-1) and inducible (COX-2) isoforms in selected
organs of the digestive tract at the end of pregnancy
in rat dams and offspring.
MATERIAL AND METHODS
Sexually mature albino rats of the Wistar
CRL:(WI)WUBR strain obtained from a commercial
breeder (Warsaw-Rembertów, Poland) were used. The
rats were acclimated for at least two weeks, housed
and maintained in an animal care facility. On mat-
ing days, females weighing 200–250 g were placed
in cages with males (5:2) for approximately 14 hours.
The following morning a vaginal smear was performed
to determine if copulation had occurred. The day
when sperm was found was designated as gestation
day 1 (GD1). Sperm-positive females were randomly
taken for the examined group (n = 8). No xenobiot-
ics were administered during the study.
On gestation day 21 the females were sacrificed.
The foetuses were delivered by caesarean section as
standard for teratological investigation [5]. All the foe-
tuses were sexed and a single non-malformed male
and female were randomly taken from each litter.
Samples of the maternal and foetal oesophagus, fore-
stomach and glandular stomach, the proximal part
of the jejunum, the distal part of the ileum, and the
transversal colon were taken during autopsy. The or-
gans from the adult animals were opened longitudi-
nally, placed on a cork board, and fixed in 10% buff-
ered formalin. The foetal organs, except for the stom-
ach, were fixed without previous opening. The appro-
priate samples were then embedded in paraffin blocks,
sectioned at 5 mm and stained routinely with haema-
toxylin and eosin (H & E) and alcian blue/periodic acid
Schiff (AB/PAS). In cases of any significant pathologi-
cal change samples were withdrawn from the study.
detected in the digestive tract of pregnant female and in foetuses. COX-1
was the predominant isoform in both the adult and foetal organs. (Folia
Morphol 2008; 67: 24–31).
Key words: cyclo-oxygenase, COX-inhibitor, lactation, NSAID,
pregnancy, prostaglandin-endoperoxide synthase, oesophagus,
stomach, small bowel, large bowel
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The immunohistochemical reaction for COX-1 and
COX-2 was performed on 4 mm slides obtained from
the paraffin blocks used previously for histological
examination. After being dewaxing and rehydrating
the slides were placed for three cycles of heating in
a microwave oven (750 W) for 5 min in citrate buffer
(0.01 M, pH 6.0) for antigen retrieval. Endogenous
peroxidase activity was blocked with 3% hydrogen
peroxide for 5 min and the slides were incubated for
60 min with the primary monoclonal mouse anti-
human antibodies (Novocastra; Newcastle, UK)
against COX-1 (clone 12E12, dilution 1:20) and COX-2
(clone 4H12, dilution 1:200). As the next step incu-
bation with DakoEnvision+TM/HRP, Mouse kit (Dako-
Cytomation, Glostrup, Denmark) was applied accord-
ing to the manufacturer’s directions. The specific
immune reaction was visualised using 3’,3-diami-
nobenzidine tetrahydrochloride (DakoCytomation)
and finally the sections were counterstained with
Mayer’s haematoxylin. TBS buffer rinsing was used
after each step. The whole procedure was performed
at room temperature. The appropriate positive and
negative controls were prepared. Sections treated in
the same way but with mouse pre-immune serum
instead of the primary antibodies examined were used
as negative controls. For the positive COX-1 and COX-2
controls, human skin and colonic mucosa were ap-
plied, respectively. Before the proper immunohis-
tochemical study was begun, cross-reactivity with
rat tissues was verified [4, 6, 7]. All the slides were
evaluated using a light microscope (Olympus BX45,
Tokyo, Japan).
RESULTS
In all cases COX-1 immunostaining was exclusive-
ly cytoplasmic. In the maternal samples a strong
positive reaction was usually found in the striated or
smooth muscle of the muscularis propria as well as
in the myocytes of the muscularis mucosae and the
blood vessels (Fig. 1A, 2A, 3A, 4A). It was also posi-
tive in the endothelium, ganglion cells of the nerve
plexus, and in the germinal centres of the lymphoid
follicles seen in the bowel mucosa. Scattered strom-
al cells with COX-1 reactivity were found in the lam-
ina propria and the adventitia (subserosa). Apart from
the keratinised layer, a strong reaction was revealed
in the stratified squamous epithelium of the oesoph-
agus and the forestomach (Fig. 1A). However, stain-
ing intensity in the epithelial cells of the glandular
stomach varied greatly from case to case. They var-
ied from completely negative to weakly positive in
the mucus-secreting cells covering the surface, the
gastric pits and the pyloric glands, as well as in the
parietal and chief cells of the fundic glands (Fig. 2A).
Weakly positive COX-1 immunostaining was also
observed in the epithelial cells of the small intestine
crypts. However in some cases, especially in the sam-
ples taken from the jejunum, enterocytes and goblet
cells lining the intestinal villi were positive as well
(Fig. 3A). In the colonic mucosa weak COX-1 stain-
ing was typical of absorptive and goblet cells both in
crypts and on the surface (Fig. 4A).
The staining pattern of the non-epithelial cells in
the foetal samples was similar to that observed in
the adult animals. However, in the epithelial cells
the COX-1 reaction was much stronger than in the
maternal samples of the corresponding organs and
comprised a majority of cells (Fig. 1B, 2B, 3B, 4B).
COX-2 immunostaining with applied monoclonal
antibody was nuclear and/or cytoplasmic. The former
was noted mainly in the epithelial cells. In the mater-
nal samples an inconsistent positive reaction was seen
in the striated or smooth muscle of the muscularis
mucosae, muscularis propria and blood vessels
(Fig. 1C, 2C, 3C, 4C). Positive staining was typical of
the scattered stromal cells of the lamina propria and
adventitia of the oesophagus and bowels, as well as
of the ganglion cells. Weak nuclear staining was found
in the stratified squamous epithelium of the oeso-
phagus and forestomach (Fig. 1C). In the maternal
glandular stomach the reaction in the epithelial cells
was negative or, in some cases, single weakly COX-
-2-positive parietal and/or mucous-secreting surface
cells were revealed (Fig. 2C). Weak COX-2 immunoex-
pression was also observed in some epithelial cells,
mostly at the base of the crypts of the small bowel
or, rarely, in epithelial cells covering the villi (Fig. 3C).
A similar weak reaction was noted in some epithelial
cells lining the crypts and colonic surface (Fig. 4C).
In the foetal samples of all the examined organs
the COX-2 immunostaining pattern was usually sim-
ilar to that of the adults, but in the glandular stom-
ach and colon the intensity of the staining, especially
in the epithelium, was stronger and involved a ma-
jority of epithelial cells (Fig. 1D, 2D, 3D, 4D).
There were no differences between male and female
foetuses in the immunoreactivity of either isoform.
DISCUSSION
The study presents the immunoreactivity of both
COX isoforms in the oesophagus, stomach, small in-
testine and colon in pregnant female rats and their
21-day old foetuses. The results are similar to previ-
ous observations concerning COX-1, while the COX-2
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immunoreaction was much stronger and/or observed
in organs and cells that were COX-2 negative in pre-
vious studies (Table 1).
In 1991 Mikkelsen et al. [18] localised cyclo-oxy-
genase in all parts of the intestine using polyclonal
COX antibody. Their results were similar to ours;
immunostaining was observed in most smooth mus-
cle cells but the reaction was much stronger in the
muscularis mucosae than in the longitudinal and cir-
cular muscle layers. Comparable expression was
Figure 1. Oesophageal immunoexpression of COX-1 (A, B) and COX-2 (C, D) in maternal (A, C) and female foetal (B, D) samples
(DakoEnvision+TM/HRP; objective magnification A–D: 20¥).
Figure 2. Gastric immunoexpression of COX-1 (A, B) and COX-2 (C, D) in maternal (A, C) and female foetal (B, D) samples
(DakoEnvision+TM/HRP; objective magnification A, C: 10¥; B, D: 20¥).
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observed in endothelial cells and in unidentified cells
in the subserosa. These observations were partially
confirmed later by immunohistochemistry with mon-
oclonal antibodies, as well as a variety of molecular
techniques. On the basis of northern and western
blot analyses [29], co-expression of COX-1 and COX-2
mRNA was detected in the canine jejunum. Similar
data were obtained for horse [20, 27] and rat [1, 2, 16]
samples. Tomlinson et al. [27] reported up-regulation
of both COX isoforms where there was intestinal
Figure 3. Enteric immunoexpression of COX-1 (A, B) and COX-2 (C, D) in maternal (A, C) and female foetal (B, D) samples
(DakoEnvision+TM/HRP; objective magnification A, C: 10¥; B, D: 20¥).
Figure 4. Colonic immunoexpression of COX-1 (A, B) and COX-2 (C, D) in maternal (A, C) and female foetal (B, D) samples
(DakoEnvision+TM/HRP; objective magnification A, C: 10¥; B, D: 20¥).
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ischaemic injury in horses. On the other hand,
ventromedial hypothalamus-lesioned rats revealed an
increase in COX-1 mRNA and a decrease in COX-2
mRNA levels in the jejunal mucosa 6 and 12 hours
after the operation [16]. However, the levels of both
isoforms increased after 24 hours. This phenomenon
was accompanied by increased proliferation of the
epithelial cells of the small intestine, probably as
a consequence of excessive prostaglandin E2 synthe-
sis. Such results were also confirmed by an experi-
ment with lipopolysaccharide administration [1]. In
contrast, Beubler et al. [2] reported that cholera toxin
did not exert any effect on the constitutive expres-
sion of COX-1 and COX-2 mRNA in the rat jejunum.
However, later studies showed that the toxin en-
hanced the COX-2 level, which remained unaffected
by dexamethasone [1]. A low physiological level of
COX-2 was previously found in the region of gut-
associated lymphoid tissue in the rat caecum [17].
Data regarding the immunolocalisation of the
constitutive and inducible COX isoforms in the oeso-
phagus and small and large bowel are sparse. How-
ever, there are a number of papers describing COX-1
and COX-2 localisation in the gastric and duodenal
mucosa. Generally COX-1 immunoexpression in var-
ious part of the digestive tract is limited to the mu-
cosal epithelium, vascular endothelium and smooth
muscle cells of the tunica muscularis. Iseki [15] ob-
served a strong immunoreactivity for COX-1 in the
rat mucous neck cells of the gastric gland. A weak
reactivity of COX-1 was also found in the mucous
cells of the cardiac and pyloric glands of the stom-
ach, as well as of Brunner’s glands of the duodenum.
The immunoreactivity of COX-2 was revealed in the
surface mucous cells in both the fundic and pyloric
gastric regions. Such observations were also con-
firmed in canines [29].
In normal human gastric mucosa COX-2 mRNA
expression was absent. However, strong expression
was observed in Helicobacter pylori-positive gastri-
tis, moderate in inflamed gastric mucosa, but with
no signs of bacterial infection [13]. The opposite re-
sults were presented by To et al. [26]. In the gastric
mucosa of healthy humans COX-1 was detected in
stromal cells in the lamina propria, while focal and
weak immunostaining for COX-2 was seen only in
the foveolar epithelium. In the case of ulceration the
immunoreactivity of COX-1 was significantly increased
in the cells of the lamina propria in the ulcer edges,
but COX-2 was strongly expressed in the hyperplas-
tic foveolar epithelium. At the ulcer base there was
a strong expression of COX-1 and COX-2 in theTa
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macrophages, myofibroblasts and the endothelial
cells of the granulation tissue. Similarly, Chan et al. [11]
reported localisation of COX-1 in the mononuclear
inflammatory, endothelial and smooth muscle cells
of the lamina propria, whereas COX-2 was reported
in the foveolar and glandular epithelium in gastritis
associated with Helicobacter pylori. In contrast to
the previously cited article [26] COX-2 but not COX-1
was elevated in the infected mucosa. Recent studies
conducted by Gudis et al. [14] using a western blot
analysis showed COX-1 protein expression only in
superficial cells of an acute ulcer, while COX-2 was
shown in both an acute and a healed ulcer. Further-
more, strong COX-1 and COX-2 immunoexpression
was found in fibroblasts and macrophages of the
ulcer base. COX-2 expression was seen in both the
fibroblasts of an ulcer and in epithelial cells and also
in the scattered mast cell-like cells and neuroendo-
crine-like cells.
It is worth mentioning that there are large varia-
tions between different organs and species in the levels
of both COX isoforms. Seibert et al. [21], who evaluat-
ed the level of COX-1 protein in various parts of the
gastrointestinal tract of dogs, found that the level in
the gastric mucosa was 10-times higher than that in
the jejunum and ileum. Inter-species comparison showed
that the highest expression of COX-1 in the small intes-
tine was observed in monkeys, humans, rodents and
dogs, respectively [17]. Such differences may explain
the oversensitivity of rats, mice and dogs to relatively
low doses of non-selective COX inhibitors.
In a recently published summary [20] COX-1 ex-
pression in adult non-pregnant rats was observed in
the stomach, duodenum, jejunum, ileum, caecum and
colon, while COX-2 reactivity was detected physio-
logically only in the caecum (Table 1). Gene expres-
sion and/or protein immunoexpression were also dem-
onstrated in the same organs in untreated adult ca-
nines, primates and humans. Contrary to our obser-
vations and some of the papers cited above [15, 16,
26, 29], the authors concluded that the COX-2 iso-
form is almost absent in these species except for low
levels in the caecum of rats and in the colon of dogs,
monkeys and humans.
There are no available data on expression of the
COX isoforms in the foetal gastrointestinal system as
there are for other foetal organs such as the brain [22],
cartilage [9, 24], heart [25], kidney [6, 24], lungs [4],
pancreas [7] and skin [24, 25]. On the other hand,
enzyme expression in the maternal tissues does not fully
cover the non-pregnant state. Since pregnancy and ear-
ly lactation alter the hormonal status [23], it strongly
influences the translation and transcription of genes
coded in both constitutive and inducible cyclo-oxy-
genase isoforms [10]. Secondary to all these chang-
es, the morphology and physiology of the maternal
digestive tract can be modified during both preg-
nancy and lactation [23]. The high physiological ex-
pression of both constitutive and inducible COX iso-
forms explains the higher level of maternal toxicity,
mostly gastrointestinal complications, previously re-
ported with non-selective COX inhibitors in pregnant
rats [8, 20].
CONCLUSION
In conclusion, it should be stressed that the con-
stitutive and inducible isoforms of cyclo-oxygenase
were detected immunohistochemically in the oeso-
phagus, stomach, ileum, jejunum and colon of preg-
nant female rats and their 21-day old foetuses. Addi-
tionally, COX-1 was the predominant isoform in the
organs of both dams and offspring.
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